These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 24372569)

  • 1. Tumor necrosis factor-α/CD40 ligand-engineered mesenchymal stem cells greatly enhanced the antitumor immune response and lifespan in mice.
    Shahrokhi S; Daneshmandi S; Menaa F
    Hum Gene Ther; 2014 Mar; 25(3):240-53. PubMed ID: 24372569
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD40ligand-expressing dendritic cells induce regression of hepatocellular carcinoma by activating innate and acquired immunity in vivo.
    Gonzalez-Carmona MA; Lukacs-Kornek V; Timmerman A; Shabani S; Kornek M; Vogt A; Yildiz Y; Sievers E; Schmidt-Wolf IG; Caselmann WH; Sauerbruch T; Schmitz V
    Hepatology; 2008 Jul; 48(1):157-68. PubMed ID: 18537185
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adenovirus-mediated CD40 ligand gene-engineered dendritic cells elicit enhanced CD8(+) cytotoxic T-cell activation and antitumor immunity.
    Liu Y; Zhang X; Zhang W; Chen Z; Chan T; Ali K; Jia Z; Xiang J
    Cancer Gene Ther; 2002 Feb; 9(2):202-8. PubMed ID: 11857039
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dendritic cells modified to express CD40 ligand elicit therapeutic immunity against preexisting murine tumors.
    Kikuchi T; Moore MA; Crystal RG
    Blood; 2000 Jul; 96(1):91-9. PubMed ID: 10891436
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potent maturation of monocyte-derived dendritic cells after CD40L lentiviral gene delivery.
    Koya RC; Kasahara N; Favaro PM; Lau R; Ta HQ; Weber JS; Stripecke R
    J Immunother; 2003; 26(5):451-60. PubMed ID: 12973034
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TGF-β1 Transduced Mesenchymal Stem Cells Have Profound Modulatory Effects on DCs and T Cells.
    Daneshmandi S; Karimi MH; Pourfathollah AA
    Iran J Immunol; 2017 Mar; 14(1):13-23. PubMed ID: 28341815
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immune Check Point CD40-CD40L Activates Dendritic and Effector Cells Against Human Renal Carcinoma Cells.
    Hillebrand RM; Vogt A; Strassburg CP; Gonzalez-Carmona MA; Schmidt-Wolf IGH
    Anticancer Res; 2019 Sep; 39(9):4643-4652. PubMed ID: 31519562
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cooperation of TNF family members CD40 ligand, receptor activator of NF-kappa B ligand, and TNF-alpha in the activation of dendritic cells and the expansion of viral specific CD8+ T cell memory responses in HIV-1-infected and HIV-1-uninfected individuals.
    Yu Q; Gu JX; Kovacs C; Freedman J; Thomas EK; Ostrowski MA
    J Immunol; 2003 Feb; 170(4):1797-805. PubMed ID: 12574344
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mesenchymal stem cells induce dendritic cell immune tolerance via paracrine hepatocyte growth factor to alleviate acute lung injury.
    Lu Z; Chang W; Meng S; Xu X; Xie J; Guo F; Yang Y; Qiu H; Liu L
    Stem Cell Res Ther; 2019 Dec; 10(1):372. PubMed ID: 31801626
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adenovector-induced expression of human-CD40-ligand (hCD40L) by multiple myeloma cells. A model for immunotherapy.
    Dotti G; Savoldo B; Takahashi S; Goltsova T; Brown M; Rill D; Rooney C; Brenner M
    Exp Hematol; 2001 Aug; 29(8):952-61. PubMed ID: 11495701
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced HER-2/neu-specific antitumor immunity by cotransduction of mouse dendritic cells with two genes encoding HER-2/neu and alpha tumor necrosis factor.
    Chen Z; Huang H; Chang T; Carlsen S; Saxena A; Marr R; Xing Z; Xiang J
    Cancer Gene Ther; 2002 Sep; 9(9):778-86. PubMed ID: 12189528
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The TNF superfamily members LIGHT and CD154 (CD40 ligand) costimulate induction of dendritic cell maturation and elicit specific CTL activity.
    Morel Y; Truneh A; Sweet RW; Olive D; Costello RT
    J Immunol; 2001 Sep; 167(5):2479-86. PubMed ID: 11509586
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative analysis of antitumor activity of CD40L, RANKL, and 4-1BBL in vivo following intratumoral administration of viral vectors or transduced dendritic cells.
    Yurkovetsky ZR; Shurin GV; Barry DA; Schuh AC; Shurin MR; Robbins PD
    J Gene Med; 2006 Feb; 8(2):129-37. PubMed ID: 16288496
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human dendritic cells engineered to express alpha tumor necrosis factor maintain cellular maturation and T-cell stimulation capacity.
    Ye Z; Chen Z; Sami A; El-Gayed A; Xiang J
    Cancer Biother Radiopharm; 2006 Dec; 21(6):613-22. PubMed ID: 17257077
    [TBL] [Abstract][Full Text] [Related]  

  • 15. T-cell-dependent antitumor effects produced by CD40 ligand expressed on mouse lung carcinoma cells are linked with the maturation of dendritic cells and secretion of a variety of cytokines.
    Tada Y; O-Wang J; Yu L; Shimozato O; Wang YQ; Takiguchi Y; Tatsumi K; Kuriyama T; Takenaga K; Sakiyama S; Tagawa M
    Cancer Gene Ther; 2003 Jun; 10(6):451-6. PubMed ID: 12768190
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intratumoral administration of low doses of an adenovirus vector encoding tumor necrosis factor alpha together with naive dendritic cells elicits significant suppression of tumor growth without toxicity.
    Kianmanesh A; Hackett NR; Lee JM; Kikuchi T; Korst RJ; Crystal RG
    Hum Gene Ther; 2001 Nov; 12(17):2035-49. PubMed ID: 11747595
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of mesenchymal stem cell-derived exosomes on the induction of mouse tolerogenic dendritic cells.
    Shahir M; Mahmoud Hashemi S; Asadirad A; Varahram M; Kazempour-Dizaji M; Folkerts G; Garssen J; Adcock I; Mortaz E
    J Cell Physiol; 2020 Oct; 235(10):7043-7055. PubMed ID: 32043593
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TNF-α modulates the immunosuppressive effects of MSCs on dendritic cells and T cells.
    Mohammadpour H; Pourfathollah AA; Zarif MN; Tahoori MT
    Int Immunopharmacol; 2015 Oct; 28(2):1009-17. PubMed ID: 26303769
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhanced protective immunity derived from dendritic cells with phagocytosis of CD40 ligand transgene-engineered apoptotic tumor cells via increased dendritic cell maturation.
    Parameswaran S; Khalil M; Ahmed KA; Sharma RK; Xiang J
    Tumori; 2015; 101(6):637-43. PubMed ID: 25983089
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interleukin-12 production by dendritic cells. The role of CD40-CD40L interactions in Th1 T-cell responses.
    Kelsall BL; Stüber E; Neurath M; Strober W
    Ann N Y Acad Sci; 1996 Oct; 795():116-26. PubMed ID: 8958922
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.